Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Toxicity of oral iron chelator L1.
Berdoukas V, Bentley P, Frost H, Schnebli HP. Berdoukas V, et al. Among authors: schnebli hp. Lancet. 1993 Apr 24;341(8852):1088. doi: 10.1016/0140-6736(93)92443-w. Lancet. 1993. PMID: 8096974 No abstract available.
Future of oral iron chelator deferiprone (L1).
Pfannkuch F, Bentley P, Schnebli HP. Pfannkuch F, et al. Among authors: schnebli hp. Lancet. 1993 Jun 5;341(8858):1480. Lancet. 1993. PMID: 8099178 No abstract available.
ICL670A: preclinical profile.
Nick H, Wong A, Acklin P, Faller B, Jin Y, Lattmann R, Sergejew T, Hauffe S, Thomas H, Schnebli HP. Nick H, et al. Among authors: schnebli hp. Adv Exp Med Biol. 2002;509:185-203. doi: 10.1007/978-1-4615-0593-8_10. Adv Exp Med Biol. 2002. PMID: 12572995 No abstract available.
Development of Eglin c as a drug: pharmacokinetics.
Nick HP, Probst A, Schnebli HP. Nick HP, et al. Among authors: schnebli hp. Adv Exp Med Biol. 1988;240:83-8. doi: 10.1007/978-1-4613-1057-0_9. Adv Exp Med Biol. 1988. PMID: 3245507 No abstract available.
73 results